Ertugliflozin/sitagliptin - Merck/Pfizer
At a glance
- Drug Originator Merck & Co; Pfizer
- Drug Class Antihyperglycaemics; Chlorobenzenes; Glycosides; Heterocyclic bicyclo compounds; Phenyl ethers; Pyrazines; Small molecules; Triazoles
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants MSD SUB MERCK
- USA Patents 9
- NDAs 1
- International Patents 139
Table of Contents
Disclaimer